It would be interesting - the SP certainly didn't move up in the lead up to topline results for trof in Retts (it definitely did in the leadup to FDA approval though, which you would expect). I think the market would put a much higher chance on 2591 approval given comparable results to-date and value accordingly but could be wrong.
Share Price, page-11811
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.56 |
Change
-0.250(1.81%) |
Mkt cap ! $1.726B | |||
| Open | High | Low | Value | Volume |
| $13.82 | $13.91 | $13.51 | $2.340M | 171.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 71 | $13.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.56 | 222 | 9 |
View Market Depth
| Last trade - 14.02pm 11/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |